Related Funds
Fund Name | Location |
Anheuser-Busch InBev | New York, New York, United States |
BioCity Group | England, Nottingham, United Kingdom |
China Great Wall Asset Management | Beijing, Beijing, China |
DeFi Alliance | - |
Encourage Capital | New York, New York, United States |
Freedom Communications | California, Santa Ana, United States |
Gedoumi.com | - |
Hangzhou Shengdoushi Shengwu Keji Youxian Gongsi | China, Hangzhou, Zhejiang |
Vogabakki | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Immupeutics Medicine | 14 Nov 2023 | - | |||
GRIT Biotechnology | 14 Jul 2021 | Shanghai, Shanghai, China | |||
Immunophage Biotech | $30M | 11 May 2021 | Shanghai, Shanghai, China | ||
Zhishan Weixin Biotechnology | 09 Feb 2021 | Chengdu, Sichuan, China | |||
IMPACT Therapeutics | $50M | 01 Dec 2020 | Xuanwu District, Jiangsu, China | ||
Stemirna | $4M | 01 Feb 2020 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Immupeutics Medicine | 14 Nov 2023 | - | |||
GRIT Biotechnology | 14 Jul 2021 | Shanghai, Shanghai, China | |||
Immunophage Biotech | $30M | 11 May 2021 | Shanghai, Shanghai, China | ||
Zhishan Weixin Biotechnology | 09 Feb 2021 | Chengdu, Sichuan, China | |||
IMPACT Therapeutics | $50M | 01 Dec 2020 | Xuanwu District, Jiangsu, China | ||
Stemirna | $4M | 01 Feb 2020 | Dongcheng District, Beijing, China |